Evidence map›Paper›PMID 29105584›Full record

ReviewWomen's health (London, England)2017

Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur?

Funlayo Odejinmi, Reeba Oliver, Rebecca Mallick

Open access · goldAbstract readReview
In one paragraph

Review in Women's health (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Funlayo OdejinmiDepartment of Gynaecology, Whipps Cross University Hospital, Barts Health NHS Trust, London, UK.
Reeba OliverDepartment of Gynaecology, Whipps Cross University Hospital, Barts Health NHS Trust, London, UK.
Rebecca MallickDepartment of Gynaecology, Whipps Cross University Hospital, Barts Health NHS Trust, London, UK.
Whipps Cross University Hospital · GBBarts Health NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulipristal acetate (Esmya

Indexed as

Antineoplastic AgentsDrug Administration ScheduleFemaleHumansLeiomyomaNorpregnadienesSeverity of Illness IndexUterine NeoplasmsWomen's HealthAntineoplastic AgentsNorpregnadienesulipristal acetateEsmyafibroidsmyomaPEARLulipristal acetate

Identifiers

PMID29105584
PMCPMC7789028
OpenAlexW2767440318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.